Skip to main content
Clinical Trials/NL-OMON26709
NL-OMON26709
Other
N/A

Contrast-induced nephropathy in patients undergoing percutaneous transluminal angioplasty in symptomatic peripheral artery disease – A prospective cohort study.

T.A. Sigterman MD, Resident general surgeryDepartment of SurgeryAtrium Medical CentreHenri Dunantstraat 56419PC Heerlen Email: timsigterman@gmail.com0 sites350 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
PAD:Peripheral artery diseaseCRI:Chronic renal insufficiencyIC:Intermittent claudicationCLI:Critical limb ischemiaGFR: Glomerular filtration ratePTA:Percutaneous transluminal angioplastyCIN:Contrast induced nephropathyPCI:Percutaneous coronary interventionCKD:Chronic kidney disease
Sponsor
T.A. Sigterman MD, Resident general surgeryDepartment of SurgeryAtrium Medical CentreHenri Dunantstraat 56419PC Heerlen Email: timsigterman@gmail.com
Enrollment
350
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
T.A. Sigterman MD, Resident general surgeryDepartment of SurgeryAtrium Medical CentreHenri Dunantstraat 56419PC Heerlen Email: timsigterman@gmail.com

Eligibility Criteria

Inclusion Criteria

  • All patients presenting at the department of vascular surgery between May 1st 2013 and February 15th 2014

Exclusion Criteria

  • Exclusion criteria were end\-stage renal disease (ESRD), no renal function test, any CT\-angiography or percutaneous coronary intervention in the first year of follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials